About
Changing Physician Behavior
Publications
Onco’Zine
The Onco’Zine Brief
The Onco’Zine Dossier
Episodes
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
Advisory Board
Join Our Editorial Advisory Board
Call for Papers
Submission Guidelines
Instructions for Authors: Introduction
Step 1: Before You Begin the Submission Process
Step 2: Prepare to Submit Your Manuscript
Download Our Media Kit
Sponsor Opportunities
Partners
Feedback
Subscribe
Contact
Articles
Editorial
News
Business & Economics
Conference Coverage
Must Read Articles
Clinical Trials Update
Peer Review
The Review
ADC Directory
Join Today
Video Library
Resources
ADC Drug Map
Resources for Clinicians
ADC Package Inserts
Clinical Trials
ADC University
Recommended Reading
ADC Review | The Bookstore
ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
Search
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Privacy Policy
Password recovery
Recover your password
your email
A password will be e-mailed to you.
ADC Review
About
Changing Physician Behavior
Publications
Onco’Zine
The Onco’Zine Brief
The Onco’Zine Dossier
Episodes
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
Advisory Board
Join Our Editorial Advisory Board
Call for Papers
Submission Guidelines
Instructions for Authors: Introduction
Step 1: Before You Begin the Submission Process
Step 2: Prepare to Submit Your Manuscript
Download Our Media Kit
Sponsor Opportunities
Partners
Feedback
Subscribe
Contact
Articles
Editorial
News
Business & Economics
Conference Coverage
Must Read Articles
Clinical Trials Update
Peer Review
The Review
ADC Directory
Join Today
Video Library
Resources
ADC Drug Map
Resources for Clinicians
ADC Package Inserts
Clinical Trials
ADC University
Recommended Reading
ADC Review | The Bookstore
ADC Review | The Bookstore – Lyophilization of Pharmaceuticals and Biologicals
ADC Review | The Bookstore – Bioconjugation: Methods and Protocols
ADC Review | The Bookstore – Biopharmaceutical Processing: Development, Design, and Implementation of Manufacturing Processes
ADC Review | The Bookstore – Analytical Characterization of Biotherapeutics
ADC Review | The Bookstore – Antibody Drug Discovery | Molecular Medicine and Medicinal Chemistry
ADC Review | The Bookstore – Next Generation Antibody Drug Conjugates (ADCs) and Immunotoxins (Milestones in Drug Therapy)
ADC Review | The Bookstore – Antibody-Drug Conjugates Methods in Molecular Biology
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
ADC Review | The Bookstore – Antibody-Drug Conjugates: Fundamentals, Drug Development, and Clinical Outcomes to Target Cancer 1st Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications
ADC Review | The Bookstore – Antibody-Drug Conjugates: Methods and Protocols (Methods in Molecular Biology) 1st ed. 2020 Edition
ADC Review | The Bookstore – Antibody-Drug Conjugates: The 21st Century Magic Bullets for Cancer
ADC Review | The Bookstore – Cytotoxic Payloads for Antibody–Drug Conjugates
ADC Review | The Bookstore – Innovations for Next-Generation Antibody-Drug Conjugates
Unlocking the Potential of Antibody-drug Conjugates
Toshimitsu Uenaka, Ph.D.
What to Consider when Scaling Fill/Finish for Cell & Gene Therapy?
AJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation Technology
FDA Grants Fast Track Designation for ARX517 in Metastatic Castration-Resistant Prostate Cancer
Bioconjugation Technology Selection during Early-Stage Development – A Strategy to Streamline IND and Manufacturing Timelines
Advertise with us
MUST READ ARTICLES
Unlocking the Potential of Antibody-drug Conjugates
What to Consider when Scaling Fill/Finish for Cell & Gene Therapy?
AJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation...
How Process Enabling Closed Systems Offer Maximum Safety in ADC Manufacturing
Accelerating Biologics R&D with Unified Software and Data Flows
Sacituzumab Govitecan Expected to Become Gilead’s Blockbuster Following Expanded Approval
Advances in the Development of Dual-Drug Antibody Drug Conjugates
Recent Advances in Antibody-drug Conjugates Produced Using Chemical Conjugation Technology
Stable, Site-Specific ADC Conjugation with SMARTag® Technology and Innovative Linker
CONFERENCE COVERAGE
Brentuximab vedotin + Immunotherapy Shows 98% ORR and 93% CR in...
Trastuzumab Deruxtecan Offers an Effective Treatment Option for Patients with Difficult-to-treat...
Mirvetuximab Soravtansine Improves Survival in Women With Recurrent Ovarian Cancer
Compared to Brentuximab Vedotin, Nivolumab Reduces Risk of Disease Progression in...
What to Expect at ASCO ’23: Mythic Therapeutics’ MYTX-011 Trial In...
Eisai & Co and Bliss Biopharmaceutical (Hangzhou) Sign Agreement to Jointly...
What to Expect at ASCO 2023: SystImmune to Present Updates on...
Peptide–drug Conjugate Sudocetaxel Zendusortide Shows Potential as a Single Agent and...
ZB131 ADC Induce Potent Anti-tumor Activity CSP-expressing Tumors
NEWS
Trastuzumab Deruxtecan Offers an Effective Treatment Option for Patients with Difficult-to-treat...
Mirvetuximab Soravtansine Improves Survival in Women With Recurrent Ovarian Cancer
Compared to Brentuximab Vedotin, Nivolumab Reduces Risk of Disease Progression in...
Acquisition of Synaffix Strengthens Lonza’s Bioconjugates Offering
Pyxis Oncology Positions Itself at the Forefront of ADC Development with...
ATG-022, a Claudin 18.2 ADC, Receives Orphan Drug Designations for the...
Accelerating Biologics R&D with Unified Software and Data Flows
LaNova Signs Exclusive License Agreement with AstraZeneca for Novel GPRC5D-Targeting ADC
Food and Drug Administration Issues Complete Response Letter for Byondis’ [Vic-]Trastuzumab...
PEER REVIEW
AJICAP Second-generation: Realizing Versatility and Robustness through Fc-Affinity Guided Chemical Conjugation...
Bioconjugation Technology Selection during Early-Stage Development – A Strategy to Streamline...
How Process Enabling Closed Systems Offer Maximum Safety in ADC Manufacturing
Automating ADC Manufacturing with Electricity
Advances in the Development of Dual-Drug Antibody Drug Conjugates
Recent Advances in Antibody-drug Conjugates Produced Using Chemical Conjugation Technology
EDITORIAL
Accelerating Biologics R&D with Unified Software and Data Flows
Project Optimus: How to Prepare for Success
The Rise of HER2-targeting ADCs and the Journey from Breakthrough Therapy...
The Complexities of the ADC Design: What’s Needed to Improve the...
Real World-Ready
The Story of World ADC Digital
THE REVIEW
Himalaya Therapeutics to Develop Conditionally Active Biologics for the Greater China...
Advisory Committee Votes in Favor of Positive Benefit/Risk Profile for Belantamab...
FDA Accepts Resubmission of Biologics License Application for Sacituzumab Govitecan
Bispecific Antibody Evolution for Cancer Therapy: Advances from Merus, Adimab, Regeneron,...
ADC Express: Rapid ADC Production from a Single Source
What Are Customized ADCs?
Sign up for Our Newsletter
Please enable JavaScript in your browser to complete this form.
Name
*
First
Last
Email
*
GDPR Agreement
*
I consent to having this website store my submitted information so they can respond to my inquiry.
By submitting this form, you are consenting to receive marketing emails from: Sunvalley Communication, publishers of ADC Review and Onco'Zine, 4960 S. Gilbert Road, Suite 1-286, Chandler, AZ 85249, US, https://www.sunvalleycommunication.com You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email.
Message
Subscribe to our Newsletter
×
Webinar: TRPH-222 Interim Ph I Data: Leveraging SMARTag® to Enhance Safety
Please enable JavaScript in your browser to complete this form.
Name
*
First
Last
Email
*
Country
*
Select
United States
Afghanistan
Albania
Algeria
Andorra
Angola
Antigua & Deps
Argentina
Armenia
Australia
Austria
Azerbaijan
Bahamas
Bahrain
Bangladesh
Barbados
Belarus
Belgium
Belize
Benin
Bhutan
Bolivia
Bosnia Herzegovina
Botswana
Brazil
Brunei
Bulgaria
Burkina
Burundi
Cambodia
Cameroon
Canada
Cape Verde
Central African Rep
Chad
Chile
China
Colombia
Comoros
Congo
Congo {Democratic Rep}
Costa Rica
Croatia
Cuba
Cyprus
Czech Republic
Denmark
Djibouti
Dominica
Dominican Republic
East Timor
Ecuador
Egypt
El Salvador
Equatorial Guinea
Eritrea
Estonia
Ethiopia
Fiji
Finland
France
Gabon
Gambia
Georgia
Germany
Ghana
Greece
Grenada
Guatemala
Guinea
Guinea-Bissau
Guyana
Haiti
Honduras
Hungary
Iceland
India
Indonesia
Iran
Iraq
Ireland {Republic}
Israel
Italy
Ivory Coast
Jamaica
Japan
Jordan
Kazakhstan
Kenya
Kiribati
Korea North
Korea South
Kosovo
Kuwait
Kyrgyzstan
Laos
Latvia
Lebanon
Lesotho
Liberia
Libya
Liechtenstein
Lithuania
Luxembourg
Macedonia
Madagascar
Malawi
Malaysia
Maldives
Mali
Malta
Marshall Islands
Mauritania
Mauritius
Mexico
Micronesia
Moldova
Monaco
Mongolia
Montenegro
Morocco
Mozambique
Myanmar, {Burma}
Namibia
Nauru
Nepal
Netherlands
New Zealand
Nicaragua
Niger
Nigeria
Norway
Oman
Pakistan
Palau
Panama
Papua New Guinea
Paraguay
Peru
Philippines
Poland
Portugal
Qatar
Romania
Russian Federation
Rwanda
St Kitts & Nevis
St Lucia
Saint Vincent & the Grenadines
Samoa
San Marino
Sao Tome & Principe
Saudi Arabia
Senegal
Serbia
Seychelles
Sierra Leone
Singapore
Slovakia
Slovenia
Solomon Islands
Somalia
South Africa
South Sudan
Spain
Sri Lanka
Sudan
Suriname
Swaziland
Sweden
Switzerland
Syria
Taiwan
Tajikistan
Tanzania
Thailand
Togo
Tonga
Trinidad & Tobago
Tunisia
Turkey
Turkmenistan
Tuvalu
Uganda
Ukraine
United Arab Emirates
United Kingdom
Uruguay
Uzbekistan
Vanuatu
Vatican City
Venezuela
Vietnam
Yemen
Zambia
Zimbabwe
State
*
Select
Alabama
Alaska
Arizona
Arkansas
California
Colorado
Connecticut
Delaware
Florida
Georgia
Hawaii
Idaho
Illinois
Indiana
Iowa
Kansas
Kentucky
Louisiana
Maine
Maryland
Massachusetts
Michigan
Minnesota
Mississippi
Missouri
Montana
Nebraska
Nevada
New Hampshire
New Jersey
New Mexico
New York
North Carolina
North Dakota
Ohio
Oklahoma
Oregon
Pennsylvania
Rhode Island
South Carolina
South Dakota
Tennessee
Texas
Utah
Vermont
Virginia
Washington
West Virginia
Wisconsin
Wyoming
Province
*
Please describe your reason for interest:
*
Considering solutions for an immediate need
Evaluating solutions for a project within 6 months
Researching solutions for a project more than 6 months away
No need for a solution, just researching the topic
GDPR Agreement
*
I consent to having this website store my submitted information so they can respond to my inquiry.
Email
Submit
×
X